These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7953508)

  • 1. Endothelial cell transformation by polyomavirus middle T antigen in mice lacking Src-related kinases.
    Kiefer F; Anhauser I; Soriano P; Aguzzi A; Courtneidge SA; Wagner EF
    Curr Biol; 1994 Feb; 4(2):100-9. PubMed ID: 7953508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src.
    Thomas JE; Aguzzi A; Soriano P; Wagner EF; Brugge JS
    Oncogene; 1993 Sep; 8(9):2521-9. PubMed ID: 7689725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ShcA and Grb2 mediate polyoma middle T antigen-induced endothelial transformation and Gab1 tyrosine phosphorylation.
    Ong SH; Dilworth S; Hauck-Schmalenberger I; Pawson T; Kiefer F
    EMBO J; 2001 Nov; 20(22):6327-36. PubMed ID: 11707404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human endothelial cells expressing polyoma middle T induce tumors.
    Primo L; Roca C; Ferrandi C; Lanfrancone L; Bussolino F
    Oncogene; 2000 Jul; 19(32):3632-41. PubMed ID: 10951569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of transformed endothelial cells in the absence of VEGFR-2/Flk-1 by Polyoma middle T oncogene.
    Mühlner U; Möhle-Steinlein U; Wizigmann-Voos S; Christofori G; Risau W; Wagner EF
    Oncogene; 1999 Jul; 18(29):4200-10. PubMed ID: 10435633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice.
    Guy CT; Muthuswamy SK; Cardiff RD; Soriano P; Muller WJ
    Genes Dev; 1994 Jan; 8(1):23-32. PubMed ID: 7507074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo.
    Muthuswamy SK; Muller WJ
    Oncogene; 1995 Nov; 11(9):1801-10. PubMed ID: 7478608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RCAS/SCL-TVA animal model allows targeted delivery of polyoma middle T oncogene to vascular endothelial progenitors in vivo and results in hemangioma development.
    Sausville J; Molinolo AA; Cheng X; Frampton J; Takebe N; Gutkind JS; Feldman RA
    Clin Cancer Res; 2008 Jun; 14(12):3948-55. PubMed ID: 18559617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide antibodies to the human c-fyn gene product demonstrate pp59c-fyn is capable of complex formation with the middle-T antigen of polyomavirus.
    Cheng SH; Harvey R; Espino PC; Semba K; Yamamoto T; Toyoshima K; Smith AE
    EMBO J; 1988 Dec; 7(12):3845-55. PubMed ID: 2463167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice.
    Stein PL; Vogel H; Soriano P
    Genes Dev; 1994 Sep; 8(17):1999-2007. PubMed ID: 7958873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rac is essential in the transformation of endothelial cells by polyoma middle T.
    Connolly JO; Soga N; Guo XL; Alvarez U; Hruska KA
    Cell Adhes Commun; 2000 May; 7(5):409-22. PubMed ID: 10830619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of p62c-yes with polyomavirus middle T-antigen mutants correlates with transforming ability.
    Kornbluth S; Cheng SH; Markland W; Fukui Y; Hanafusa H
    J Virol; 1990 Apr; 64(4):1584-9. PubMed ID: 1690822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular targeting of pp60src expression: localization of v-src to adhesion plaques is sufficient to transform chicken embryo fibroblasts.
    Liebl EC; Martin GS
    Oncogene; 1992 Dec; 7(12):2417-28. PubMed ID: 1334249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment.
    Williams RL; Risau W; Zerwes HG; Drexler H; Aguzzi A; Wagner EF
    Cell; 1989 Jun; 57(6):1053-63. PubMed ID: 2736622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyoma middle T-induced vascular tumor formation: the role of the plasminogen activator/plasmin system.
    Sabapathy KT; Pepper MS; Kiefer F; Möhle-Steinlein U; Tacchini-Cottier F; Fetka I; Breier G; Risau W; Carmeliet P; Montesano R; Wagner EF
    J Cell Biol; 1997 May; 137(4):953-63. PubMed ID: 9151696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mice transgenic with SV40-late-promoter-driven Polyomavirus Middle T oncogene exclusively develop hemangiomas.
    Xu Q; Chen W; Wang Z; Zheng J; Zhang Z
    Transgenic Res; 2009 Jun; 18(3):399-406. PubMed ID: 19067215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein tyrosine phosphatase epsilon activates Yes and Fyn in Neu-induced mammary tumor cells.
    Granot-Attas S; Elson A
    Exp Cell Res; 2004 Mar; 294(1):236-43. PubMed ID: 14980517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversion of middle T antigen-transformed Rat-2 cells by Krev-1: implications for the role of p21c-ras in polyomavirus-mediated transformation.
    Jelinek MA; Hassell JA
    Oncogene; 1992 Sep; 7(9):1687-98. PubMed ID: 1380149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells.
    Twamley-Stein GM; Pepperkok R; Ansorge W; Courtneidge SA
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7696-700. PubMed ID: 8356071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling.
    Denis D; Rouleau C; Schaffhausen BS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27852846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.